Latest Investments News

Pure Hydrogen Corporation Limited is set to unlock value by spinning out its Australian gas assets into Eastern Gas Limited, offering shareholders free shares in the new entity. The move positions Eastern Gas to capitalize on strong East Coast gas market demand with an anticipated $8–10 million IPO.

Janus Henderson Investors has announced an estimated distribution of 22.0378 cents per unit for its Sustainable Credit Active ETF for the period ending 31 January 2025, with key dates set for early February.

Starpharma reports encouraging FDA feedback on its DEP® SN38 candidate for ovarian cancer and prepares for product launches in Saudi Arabia and UAE, supported by a solid $20.3 million cash position.

Austral Resources Australia Ltd reports steady operational progress and promising resource developments in its December 2024 quarter, while navigating an ongoing recapitalisation and leadership transition.

McLaren Minerals is set to begin a six-week drilling campaign at its McLaren Titanium Project in Western Australia, aiming to boost resource confidence and explore deposit extensions.

ReNerve Limited has reported a remarkable 260% increase in quarterly sales following its successful IPO, alongside strategic distribution deals in Hong Kong and the Middle East. The company is poised for further growth with upcoming clinical data and product developments.

Jupiter Energy Limited reported a net operating cash inflow of $776,000 for the December 2024 quarter, maintaining a solid cash position despite heavy exploration expenditures.

Brazilian Rare Earths Limited reports unprecedented ultra-high-grade rare earth intercepts and significant district-scale mineral discoveries at its Monte Alto project, alongside key permitting milestones advancing its mining ambitions.

Global Lithium Resources pauses Definitive Feasibility Study on its flagship Manna Lithium Project due to challenging lithium markets, while advancing strategic acquisitions and exploration in Western Australia.

Alpha HPA Limited has reached a major funding milestone with a $400 million senior debt package for its HPA First Project Stage 2, while experiencing accelerating demand from the semiconductor sector and advancing new product developments.

Neurotech International reports key clinical progress in paediatric neurological disorders, securing FDA orphan drug designation for its Rett Syndrome treatment and advancing pivotal trials for ASD and PANDAS/PANS.

Victory Metals advances its North Stanmore Heavy Rare Earth Project with a strategic offtake MOU signed with Sumitomo Corporation and a significant upgrade to its mineral resource estimate, reinforcing its position in the critical rare earths sector.